Entity Common Stock, Shares Outstanding of Silence Therapeutics plc from 31 Dec 2020 to 31 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Silence Therapeutics plc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2020 to 31 Jan 2026.
  • Silence Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2026 was 141,701,848, a 0.02% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Silence Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 141,701,848 +27,774 +0.02% 31 Jan 2026 10-K 05 Mar 2026 2025 FY
Q3 2025 141,701,848 30 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 141,701,848 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 141,690,850 21 Apr 2025 10-K/A 30 Apr 2025 2024 FY
Q4 2024 141,674,074 +22,827,108 +19% 31 Jan 2025 10-K 27 Feb 2025 2024 FY
Q4 2023 118,846,966 +11,038,495 +10% 31 Dec 2023 20-F 13 Mar 2024 2023 FY
Q4 2022 107,808,471 +18,023,751 +20% 31 Dec 2022 20-F 15 Mar 2023 2022 FY
Q4 2021 89,784,720 +6,478,461 +7.8% 31 Dec 2021 20-F 17 Mar 2022 2021 FY
Q4 2020 83,306,259 31 Dec 2020 20-F/A 29 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.